Isogenic
  • Home
  • Sitemap
  • Design
    • Purpose of study
    • Ethics
    • Experimental Designs
    • Sample size
    • Species & strain
    • Uniformity
    • Experimental unit
    • Randomisation
    • Blinding
    • Statistical analysis
    • Treatments
    • Practicalities
    • Outcomes
    • Presenting results
    • Literature
  • Isogenic
    • Quotes from geneticists
    • Toxicity testing
    • Outbred stocks
    • Multi-strain experiments
    • Isogenic strains
    • Ethical considerations
    • FAQs
  • Animal models
  • Author

Temporary

Data sets for a FELASA Category C course on experimental design and statistics, Madrid, April 2010

Data set 1. 1-way ANOVA with outliers

Micronucleus counts

Control Urethane   MCA

1.48 3.04 1.26
2.23 3.48 2.13
1.87 2.49 1.87
1.88 3.56 0.75
1.9  6.10  2.00
1.59 2.81 1.98
1.23 3.85 2.27
2.06 2.90 2.34
2.15 5.39 1.55
0.66 1.57 2.26
0.33 2.15 1.76
1.22 2.34 0.83

Data set 2 Platelet counts in groups of rats One-way ANOVA, unequal variances

Platelet count in six groups of rats

Group  Count
Ctrl 415
Ctrl 500
Ctrl 395
Ctrl 430
Ctrl 415
Ctrl 450
Ctrl 484
Ctrl 520
Ctrl 424
Ctrl 479

Vehicle 435
Vehicle 440
Vehicle 292
Vehicle 320
Vehicle 459
Vehicle 440
Vehicle 323
Vehicle 510
Vehicle 375

NER654 430
NER654 457
NER654 380
NER654 500
NER654 542
NER654 491
NER654 505
NER654 549

BBN  615
BBN  512
BBN  590
BBN  527
BBN  705
BBN  560
BBN  420
BBN  570
BBN  407
BBN  442
BBN  333
BBN  554

BBNNER 996
BBNNER 737
BBNNER 600
BBNNER 540
BBNNER 433
BBNNER 535
BBNNER 855
BBNNER 545
BBNNER 445
BBNNER 695
BBNNER 585
BBNNER 775
BBNNER 748
BBNNER2 705
BBNNER2 630
BBNNER2 490
BBNNER2 675
BBNNER2 603
BBNNER2 536
BBNNER2 485
BBNNER2 498
BBNNER2 532
BBNNER2 493
BBNNER2 557
BBNNER2 847

Data set 3. Regression analysis

Lesion diameter in pigs

Power Diameter

50 3.3
50 3.2
50 2.8
50 2.8
50 2.4
50 2.7
50 3.2
50 3.8
50 1.5
100 4.7
100 4.0
100 3.5
100 4.4
100 3.9
100 4.8
100 4.4
100 3.7
100 4.0
150 5.5
150 5.0
150 4.4
150 4.5
150 6.0
150 6.5
150 5.0
150 5.0
200 5.8
200 6.0

Data set 4. Randomised block Apoptosis

Apoptosis randomised block

Week Trt apoptosis

Wk1 1 365
Wk1 2 398
Wk1 3 421
Wk2 1 423
Wk2 2 432
Wk2 3 459
Wk3 1 308
Wk3 2 320
Wk3 3 329

Treatments

1=control
2=CGP
3=STAU

Data set 5. Rand. Block with replication

Lab  mutants Trt

1 11.8 Control
1 11.3 Control
2 10.3 Control
2 9.5 Control
3 6.5 Control
3 3.9 Control
4 5.4 Control
4 6.2 Control
5 14.2 Control
5 15.2 Control
1 18.8 L.Dose
1 20.6 L.Dose
2 16.8 L.Dose
2 13 L.Dose
3 2.4 L.Dose
3 3.9 L.Dose
4 11.7 L.Dose
4 11.6 L.Dose
5 21.2 L.Dose
5 13.7 L.Dose
1 16.4 H.Dose
1 23.4 H.Dose
2 13.2 H.Dose
2 14.6 H.Dose
3 8.4 H.Dose
3 8.6 H.Dose
4 12.4 H.Dose
4 12.2 H.Dose
5 22.5 H.Dose
5 15.8 H.Dose

Dataset 6 Taste preference

Percent  Cage Treatment

54.9 1 Water
48.2 2 Water
49.9 3 Water
50.4 4 Water
69.6 1 Saccharin
61.1 2 Saccharin
58.2 3 Saccharin
55.3 4 Saccharin
61.9 1 Salt
43.9 2 Salt
53.4 3 Salt
50.7 4 Salt
78.3 1 Sucrose
81.5 2 Sucrose
74.7 3 Sucrose
73.6 4 Sucrose
69.4 1 Ethanol
60.9 2 Ethanol
68.5 3 Ethanol
64.5 4 Ethanol

Data set 7 Paired design

Strain     Treated       Control
A/J  22.8 21.8
A2G  24 23.2
BALB/c 22.3 21.5
CBA  20.6 20.5
C3H  24 23.9
C57BL/6 24.8 24.7
DBA/2  22.4 21.7
NIH  29.6 30

Data set 8 2×2 factorial no interaction
Strain RBC Treatment
BALB/c 10.1 Control
BALB/c 10.08 Control
BALB/c 9.73 Control
BALB/c 10.09 Control
C57BL  9.6 Control
C57BL  9.56 Control
C57BL  9.14 Control
C57BL  9.2 Control
BALB/c 8.95 Treated
BALB/c 8.45 Treated
BALB/c 8.68 Treated
BALB/c 8.89 Treated
C57BL  8.82 Treated
C57BL  8.24 Treated
C57BL  8.18 Treated
C57BL  8.1 Treated

Dataset 9  2×2 factorial with interaction

Strain RBC Treatment
C3H 7.85 Control
C3H 8.77 Control
C3H 8.48 Control
C3H 8.22 Control
CD-1 9.01 Control
CD-1 7.76 Control
CD-1 8.42 Control
CD-1 8.83 Control
C3H 7.81 Treated
C3H 7.21 Treated
C3H 6.96 Treated
C3H 7.1 Treated
CD-1 9.18 Treated
CD-1 8.31 Treated
CD-1 8.47 Treated
CD-1 8.67 Treated

Data set 10  EROD Factorial randomised block

Strain Treatment Block EROD
A/J  T 1 18.7
129/Ola T  1 17.9
NIH  T 1 19.2
BALB/c T 1 26.3
A/J  C 1 7.7
129/Ola C  1 8.4
NIH  C 1 9.8
BALB/c C 1 9.7
A/J  T 2 16.7
129/Ola T  2 14.4
NIH  T 2 12
BALB/c T 2 19.8
A/J  C 2 6.4
129/Ola C  2 6.7
NIH  C 2 8.1
BALB/c C 2 6

Dataset 11 Tamoxifen

mRNA Treatment Strain
12.067 Control F344
2.992 Control F344
7.844 Control F344
3.356 Control Wistar
3.5 Control Wistar
5.64 Control Wistar
3.636 Control LEW
2.161 Control LEW
3.441 Control LEW
1.712 Tamoxifen F344
2.827 Tamoxifen F344
2.825 Tamoxifen F344
4.84 Tamoxifen Wistar
4.341 Tamoxifen Wistar
9.148 Tamoxifen Wistar
27.58 Tamoxifen LEW
19.7 Tamoxifen LEW
4.533 Tamoxifen LEW

  • Home
  • Sitemap
  • Design
  • Isogenic
  • Animal models
  • Author

Copyright © 2023 www.isogenic.info. All rights reserved.